Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy™ Series - A Focus on MSI-High and TMB-High Cancers held virtually on November 3, 2021 are available here.Program Organizers
Program Summary
Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty.
Program Learning Objectives
Please note on-demand recordings are not available for continuing education credits.
#AdvancesinCancerImmunotherapy(ACI)#2021#Tumormutationalburden(TMB)#PresentationSlides#Video
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Young Kwang Chae, MD, MPH, MBA – Northwestern University; Daniel McGrail, PhD – The University of Texas MD Anderson Cancer Center; Zsofia Stadler, MD – Memorial Sloan Kettering Cancer Center; John Strickler, MD – Duke University Medical Center; Date: November 3, 202100:56:25
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Mohamed Salem, MD – Atrium Health; Date: November 3, 202100:25:16
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Theresa S. Brown, PharmD, BCOP – Duke University Hospital; Date: November 3, 202100:20:00
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Zsofia Stadler, MD – Memorial Sloan Kettering Cancer Center; Date: November 3, 202100:21:54
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Neil Segal, MD, PhD– Memorial Sloan Kettering Cancer Center; Date: November 3, 202100:30:04
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Nicholas DeVito, MD – Duke University Hospital; Date: November 3, 202100:30:35
Meeting: 2021-2022 Advances in Cancer Immunotherapy™ - A Focus on MSI-High and TMB-High Cancers; Presenter: Funda Meric-Bernstam, MD– The University of Texas MD Anderson Cancer Center; Date: November 3, 202100:30:34
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us